treprostinil 0.1 MG/ML Injectable Solution [Remodulin]
- RxCUI
- 2667750
- RxNorm name
- treprostinil 0.1 MG/ML Injectable Solution [Remodulin]
- Display name
- treprostinil 0.1 MG/ML Injectable Solution [Remodulin]
- Full name
- treprostinil 0.1 MG/ML Injectable Solution [Remodulin]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Remodulin | TREPROSTINIL | United Therapeutics Corporation | 6c80bb38-e8db-4138-9f0d-dbbf9c673185 | 2026-07-02 | Warnings, Adverse reactions | 2667750 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6c80bb38-e8db-4138-9f0d-dbbf9c673185 | treprostinil 0.1 MG/ML Injectable Solution [Remodulin] | SBD | 33 | These highlights do not include all the information needed to use REMODULIN safely and effectively. See full prescribing information for REMODULIN. REMODULIN ® (treprostinil) Injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002 | 20250718 |
| 6c80bb38-e8db-4138-9f0d-dbbf9c673185 | Remodulin 0.1 MG/ML Injectable Solution | PSN | 33 | These highlights do not include all the information needed to use REMODULIN safely and effectively. See full prescribing information for REMODULIN. REMODULIN ® (treprostinil) Injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002 | 20250718 |
| 6c80bb38-e8db-4138-9f0d-dbbf9c673185 | Remodulin 0.1 MG/ML Injectable Solution | SY | 33 | These highlights do not include all the information needed to use REMODULIN safely and effectively. See full prescribing information for REMODULIN. REMODULIN ® (treprostinil) Injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002 | 20250718 |